DiQi Pharmaceuticals focuses on the development and industrialization of Class Ⅱ innovative drugs and drug delivery technologies, with six innovative technology platforms with independent intellectual property rights, including long-acting formulation technology, targeted nanotechnology, sustained-release technology, polyethylene glycol technology, biodegradable excipients, and generic drug development.
DiQi Pharmaceuticals provides technical support, including technical services, consulting, product development, and industrialization, to domestic and foreign pharmaceutical companies, innovative drug research and development enterprises, drug production enterprises, and other partners through various means such as cooperative development, technology authorization, and commissioned development.
